A monoclonal antibody, designated CF8 and prepared against fimbrial protein enrichments of Bordetella bronchiseptica 110H, was determined by immunogold electron microscopy to bind to some In this paper, we describe the production of a monoclonal antibody, designated CF8, which exhibits specificity for * Corresponding author. nondenatured B. bronchiseptica fimbriae. This antibody exhibits a pattern of reactivity similar to that of monoclonal antibody BPF2, which is specific for B. pertussis serotype 2 fimbriae (11). Preparations enriched in fimbrial proteins were obtained from B. bronchiseptica strains in each of the three most common electromorphotypes identified by Musser et al., ET1, ET6, and ET16. There were large differences in the amount of the 24-kDa fimbrial subunit protein produced by each strain. Since this protein was identified by Western blot (immunoblot) as being antigenically related to B. pertussis serotype 2 fimbrial subunits, an enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody CF8 was developed in order to quantitate these differences. This assay indicated that there are significant differences in the amounts of CF8-reactive fimbriae between strains. These differences did not correlate with enzyme electromorphotype but did correspond to the host species from which the strain was isolated, suggesting that the amount of serotype 2 cross-reactive fimbriae produced by strains of B. bronchiseptica may be involved in the determination of host specificity.
Bordetella bronchiseptica has been previously associated with atrophic rhinitis in pigs and acute tracheobronchitis (kennel cough) in dogs (2, 15) . B. bronchiseptica is also commonly isolated from the respiratory tracts of several other animals, including rabbits and guinea pigs (12) . Musser et al. (12) used multilocus enzyme electrophoresis to compare strains isolated from different animal species. They found that strains isolated from pigs were predominately in one electromorphotype, which was designated ET1. Strains isolated from guinea pigs were in ET16, and most strains in ET6 were isolates from dogs (12) . These data indicated that there are measurable differences between strains isolated from different species. Electromorphotype groups, defined by Musser et al., were based on the electrophoretic mobilities of 15 metabolic enzymes. Studies have not been undertaken to determine whether virulence factors or adhesins might also differ between strains isolated from different host species.
B. bronchiseptica produces most of the virulence factors identified in Bordetella pertussis, including filamentous hemagglutinin (FHA) (8) , a 68-kDa protein similar to pertactin (5), adenylate cyclase toxin (1) , and fimbriae (10) . As in B. pertussis, attachment is believed to be mediated by the combined effect of more than one of these proteins. Fimbriae are involved in attachment in several other bacterial species and may play a role in attachment by B. bronchiseptica (6, 14, 18) . Three proteins have been identified as fimbrial subunit proteins in B. bronchiseptica (10) . If fimbriae are involved in attachment, then differences in these three fimbrial proteins may contribute to the differences in host specificity observed by Musser et al. In this paper, we describe the production of a monoclonal antibody, designated CF8, which exhibits specificity for * Corresponding author. nondenatured B. bronchiseptica fimbriae. This antibody exhibits a pattern of reactivity similar to that of monoclonal antibody BPF2, which is specific for B. pertussis serotype 2 fimbriae (11) . Preparations enriched in fimbrial proteins were obtained from B. bronchiseptica strains in each of the three most common electromorphotypes identified by Musser et al., ET1, ET6, and ET16. There were large differences in the amount of the 24-kDa fimbrial subunit protein produced by each strain. Since this protein was identified by Western blot (immunoblot) as being antigenically related to B. pertussis serotype 2 fimbrial subunits, an enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody CF8 was developed in order to quantitate these differences. This assay indicated that there are significant differences in the amounts of CF8-reactive fimbriae between strains. These differences did not correlate with enzyme electromorphotype but did correspond to the host species from which the strain was isolated, suggesting that the amount of serotype 2 cross-reactive fimbriae produced by strains of B. bronchiseptica may be involved in the determination of host specificity.
MATERIALS AND METHODS
Bacterial strains, media, and growth conditions. The B. bronchiseptica strains used have been described previously (4, 12) except for strain R-5, which is a guinea pig lung isolate received from W. Shek, Charles River Laboratories. The strains used in this study and the species from which they were originally isolated are listed in Tables 1 and 2 For immunogold electron microscopy, bacterial cells were labeled by floating bacterium-coated grids first on drops of monoclonal antibody for 30 min and then on gold-conjugated goat anti-mouse IgG (5 nm in diameter) (Janssen Life Sciences Products, Beerse, Belgium) for 30 min. Initial blocking and all washes and antibody dilutions were with PBS containing 2% bovine serum albumin (BSA). Cells were negatively stained with potassium phosphotungstic acid and were examined by transmission electron microscopy as previously described (3).
For dot blot immunoassays, bacteria from 48-h brucella agar cultures were suspended in PBS and inactivated by adding formalin to a final concentration of 0.25% and holding them overnight at 37°C. This suspension was diluted in PBS to an optical density of 1.2 at 465 nm. Five microliters of the suspension was spotted onto nitrocellulose strips which had been premoistened with TBS. Enzyme-based detection of the reactivities of these spots with monoclonal antibodies was performed as described for Western blot assays. A 1:3 dilution of CF8 culture supernatant was used. In addition to that with CF8, reactivity with monoclonal antibody BPF2 was determined. BPF2 is specific for nondenatured B. pertussis serotype 2 fimbriae (11) and was kindly provided by Michael J. Brennan, Center for Biologics Evaluation and Research, Food and Drug Administration. Bacterial suspensions prepared in the same manner as that for the dot blots were used in microagglutination assays. Equal volumes of bacterial suspension were added to each well, and plates were sealed, shaken to mix, and incubated at 37°C for 2 h and at 4°C for 18 to 24 h. Agglutination was determined visually.
ELISA. B. bronchiseptica 11OH was grown for 2 days on brucella agar plates. Colonies exhibiting virulent-phase morphologies were picked and suspended in carbonate buffer (19 mM/10 mM sodium carbonate and 2.93 g of sodium bicarbonate, both per liter [pH 9.6]) to an optical density of 0.4 at 595 nm. Immulon 4 plates (Dynatech Laboratories, Chantilly, Va.) were coated with this suspension and left overnight. The B. bronchiseptica strains to be tested were grown for 2 days on Bordet-Gengou agar. Colonies exhibiting a virulent-phase phenotype were picked and suspended in wash buffer (10 mM Tris, 0.9% NaCl, 0.05% Tween 20 [pH 7.4] ) to an optical density of 0.6 at 595 nm. Dilutions of ascites fluid containing monoclonal antibody CF8 were made in the bacterial suspensions, and the suspensions were incubated at 37°C for 1 h. Bacteria were removed by centrifugation in a microcentrifuge for 15 min, and 100 pL. of the supernatant was added to the wells of the microtiter plates that had been coated with strain 11OH and blocked by incubation for 30 min in wash buffer. The plates were incubated for 1 h at 37°C and washed, and goat anti-mouse with high-molecular-mass proteins, producing a laddering effect. When the sample boiling time was increased to 5 min, no reactivity with CF8 was observed with high-molecularmass proteins or with 21-to 24-kDa fimbrial subunit proteins. Therefore, monoclonal antibody CF8 recognizes an epitope present on nondenatured or oligomeric fimbrial units which is not present on fully denatured or monomeric fimbrial subunits obtained by treatment of fimbrial enrichments with SDS and 3-mercaptoethanol and by boiling for 5 min. A similar laddering pattern has been seen previously with monoclonal antibody BPF2 (11), which recognizes nondenatured B. pertussis serotype 2 fimbriae.
Since FHA from B. pertussis also appears as a series of high-molecular-mass bands on SDS polyacrylamide gels and the fimbrial protein enrichments used as antigens for the production of monoclonal antibody CF8 were not pure fimbrial preparations and could have contained FHA, it was necessary to determine whether the bands being recognized by CF8 were nondenatured fimbriae or FHA. Western blots with monoclonal antibody Fl, which is specific for B. pertussis FHA and cross-reacts with FHA from B. bronchiseptica (8), were performed on purified FHA and on fimbrial protein enrichments (Fig. 2) . Monoclonal antibody Fl did not react with the fimbrial protein enrichment, and monoclonal antibody CF8 did not react with the purified FHA.
Fimbrial protein profiles. It has previously been reported that strain 110H possesses multiple fimbrial subunit proteins visible on polyacrylamide gels in denaturing conditions (10). It has not been determined whether each of these fimbrial subunit proteins represents a different fimbrial type. Since monoclonal antibody CF8 reacted differently with strains 11OH, 17640, and R-5, and since reactivity with CF8 has been associated with serotype 2 fimbriae, we wanted to determine whether variations in the amount of any of these major fimbrial subunit proteins corresponded to reactivity with monoclonal antibody CF8. Strains which reacted poorly with monoclonal antibody CF8 should have less of the fimbrial subunit proteins associated with serotype 2 fimbriae. Fimbrial protein profiles were determined for three strains of B. bronchiseptica (Fig. 3A) . Three predominant proteins with relative molecular masses of 21, 22, and 24 kDa were observed. These proteins appeared to be identical in molecular mass to those previously identified as fimbrial subunit proteins (10) . Strain 11OH produced large amounts of each of the fimbrial proteins; strain R-5 produced much less of the 24-kDa protein than the other two proteins. Strain 17640 produced only small amounts of both the 24-and the 22-kDa proteins. These strains consistently produced the same fimbrial protein profile upon repeated preparations. Thus, it appeared that the 24-kDa protein was the only readily identifiable band which corresponded to CF8 reactivity.
To determine whether this 24-kDa fimbrial subunit protein is serotype 2 cross-reactive, Western blots were performed with monoclonal antibody BPA5, which reacts with B. pertussis serotype 2 fimbrial subunits. These blots indicated that the 24-kDa protein is present in fimbrial protein enrichments from each of these three strains, even though in strain 17640 it is not easily visible on Coomassie blue-stained gels (Fig. 3B) pigs, and strains isolated from dogs exhibited considerable variation in antibody reactivity.
By the general linear model analysis of variance procedure on the SAS system, the difference between these three groups was found to be significant (P c 0.0002). Bonferroni t tests and the Ryan-Einot-Gabriel-Welsch multiple F-test procedures indicated that strains from pigs and guinea pigs could be placed into separate groups in terms of their reactivities with monoclonal antibody CF8. However, because of the high degree of variability in strains isolated from dogs, certain strains from dogs could be grouped with those from pigs or guinea pigs. Figure 4 illustrates the relationship between these three groups of strains.
Reactivity with antifimbrial monoclonal antibody CF8 does not seem to correspond with enzyme electromorphotype (Fig. 5) . Canine isolates in ET1 do not all exhibit the same high reactivity as porcine isolates from ET1. In addition, strains from dogs in ET1 exhibit increased variation, as do canine isolates from other enzyme electromorphotypes. Porcine isolates from enzyme electromorphotypes other than ET1 are rare. Therefore, only two strains isolated from pigs outside of ET1 were tested. These strains both exhibited levels of reactivity similar to those for porcine isolates in ET1. We were unable to obtain any strains isolated from guinea pigs in enzyme electromorphotypes other than ET16, but strains in ET16 isolated from animals other than guinea pigs did not react at the same level as strains from guinea pigs.
The reduction in titer after incubation with particular strains of B. bronchiseptica could be due to the presence of a protease or an IgG-binding protein rather than specific binding of the antibody to fimbriae. To examine this possibility, the same assay was performed with BSA as the antigen and commercially available monoclonal anti-BSA (Sigma, St. Louis, Mo.) in place of CF8. If the differences in reactivity between strains are due to a protease or an IgG-binding protein, then the same differences would be seen with an antibody which should not specifically recognize a Bordetella antigen. The anti-BSA was preincubated with an avirulent-phase strain, strain 110H, strain 17640, and strain R-5. None of these strains caused a reduction in titer, indicating that the antibody was not being bound by or proteolytically degraded by these Bordetella strains. The differences in reactivity with CF8 correlate with the host species from which each strain was isolated. Strains isolated from pigs and guinea pigs each exhibited a tight range of reactivity, with strains from pigs having significantly more reactivity with CF8 than those from guinea pigs.
This observation suggests that there may be an increased need for the presence of serotype 2 cross-reactive fimbriae for infection of pigs by B. bronchiseptica. At present, it is not known whether strains which infect pigs exhibit high levels of serotype 2 cross-reactive fimbriate before colonization or some unidentified environmental factor present in the porcine respiratory tract induces antigenic switching to this type of fimbriae. Switching of fimbrial serotypes has been previously documented with Neisseria species (16) . Robinson et al. observed selection for particular fimbrial serotypes after immunization of mice with B. pertussis. They suggested that the recovery of fimbrial serotypes other than those present in the inoculum could be due to fimbrial serotype switching (13) .
Canine isolates exhibited a much broader range of reactivity with CF8 than strains from either pigs or guinea pigs. Strains isolated from dogs included both strain 110H, which is highly reactive with CF8, and strain Romark, the least reactive strain tested from any of these three animals. This increased variability is not surprising considering that Musser et , all exhibit levels of reactivity similar to those of the other strains from pigs. B. bronchiseptica strains from ET16, which were isolated from animals other than guinea pigs, do not fall into the narrow range of reactivity of strains from guinea pigs. This lack of correlation of reactivity with enzyme electromorphotype is interesting, since Musser et al. found a definite correlation between enzyme electromorphotype and host species (12) . This observation suggests that more than one factor may be involved in the determination of host specificity. It is also interesting to speculate that if fimbriae are playing a role in the determination of host specificity in B. bronchiseptica, then the presence or absence of particular fimbrial traits may be responsible for the restriction of B. pertussis to human hosts. Both B. pertussis and B. bronchiseptica produce fimbriae reactive with serotype 2-specific antibodies, but these fimbriae are not necessarily identical because they share this particular epitope.
From the data presented, four major conclusions can be reached: (i) fimbrial protein profiles differ between B. bronchiseptica strains, (ii) strains isolated from pigs express more CF8-reactive and presumably more B. pertussis serotype 2 cross-reactive fimbriae than strains isolated from guinea pigs, (iii) B. bronchiseptica strains isolated from dogs vary greatly in the amount of CF8 reactive fimbriae that they express, and (iv) expression of CF8-reactive and B. pertussis serotype 2 cross-reactive fimbriae does correlate with host species but does not correlate with enzyme electromorphotype. These observations support the idea that CF8-reactive and B. pertussis serotype 2 cross-reactive fimbriae are involved in the determination of host specificity of B. bronchiseptica.
